Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Harmony Biosciences Holdings
HRMYCurrent price
32.72 USD
-0.1 USD (-0.30%)
Last closed
32.72 USD
Company
www.harmonybiosciences.com
ISIN
US4131971040
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 885 454 848 USD
Yield for 12 month
+2.31 %
1Y
3Y
5Y
10Y
15Y
HRMY
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania. Address: 630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
49.50 USDP/E ratio
15.67Dividend Yield
–Current Year
+582 022 000 USD
Last Year
+437 855 000 USD
Current Quarter
+186 038 000 USD
Last Quarter
+172 814 000 USD
Current Year
+460 786 000 USD
Last Year
+354 374 000 USD
Current Quarter
+143 260 000 USD
Last Quarter
+134 709 000 USD
Key Figures HRMY
1 year
3 years
5 years
10 years
EBITDA
199 564 000 USD
Operating Margin TTM
Price to Earnings
15.67
Return On Assets TTM
12.85 %
PEG Ratio
–
Return On Equity TTM
22.75 %
Wall Street Target Price
49.50 USD
Revenue TTM
681 878 976 USD
Book Value
10.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
16.10 %
Dividend Yield
–
Gross Profit TTM
354 374 000 USD
Earnings per share
2.11 USD
Diluted Eps TTM
2.11 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
25.40 %
Profit Margin
17.98 %
Dividend Analytics HRMY
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History HRMY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation HRMY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
15.67
Forward PE
8.15
Enterprise Value Revenue
2.43
Price Sales TTM
2.77
Enterprise Value EBITDA
7.62
Price Book MRQ
3.16
Financials HRMY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HRMY
For 52 weeks
28.14 USD
41.61 USD
50 Day MA
34.29 USD
Shares Short Prior Month
5 798 106
200 Day MA
33.02 USD
Short Ratio
4.94
Shares Short
5 445 550
Short Percent
42.12 %
BeatStart